TIAA CREF INVESTMENT MANAGEMENT LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 144 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2019$975,000
+90.8%
253,169
-7.4%
0.00%
Q4 2018$511,000
-71.0%
273,450
-50.3%
0.00%
-100.0%
Q3 2018$1,760,000
+104.4%
550,120
+92.9%
0.00%0.0%
Q2 2018$861,000
-28.2%
285,218
-6.7%
0.00%0.0%
Q1 2018$1,199,000
-4.5%
305,841
+0.8%
0.00%0.0%
Q4 2017$1,256,000
-40.8%
303,407
-12.2%
0.00%0.0%
Q3 2017$2,122,000
-2.7%
345,560
-1.4%
0.00%
-50.0%
Q2 2017$2,180,000
+4.8%
350,435
+6.8%
0.00%
+100.0%
Q1 2017$2,080,000
-4.3%
328,087
-19.2%
0.00%
-50.0%
Q4 2016$2,173,000
-9.8%
406,171
-5.0%
0.00%0.0%
Q3 2016$2,408,000
-4.2%
427,629
-6.6%
0.00%0.0%
Q2 2016$2,514,000
-24.3%
457,849
+2.4%
0.00%
-33.3%
Q1 2016$3,319,000
-6.7%
447,313
+4.5%
0.00%0.0%
Q4 2015$3,558,000
+4.4%
428,102
+13.2%
0.00%0.0%
Q3 2015$3,407,000
-27.0%
378,173
-2.7%
0.00%0.0%
Q2 2015$4,666,000
+34.9%
388,808
+21.1%
0.00%
+50.0%
Q1 2015$3,458,000
+122.7%
321,085
+4.8%
0.00%
+100.0%
Q4 2014$1,553,000
+82.3%
306,343
-5.1%
0.00%0.0%
Q3 2014$852,000
-36.7%
322,651
-3.4%
0.00%0.0%
Q2 2014$1,345,000
-8.5%
333,863
+4.0%
0.00%0.0%
Q1 2014$1,470,000
+2.7%
320,933
-2.7%
0.00%0.0%
Q4 2013$1,431,000
+43.8%
329,713
+30.9%
0.00%0.0%
Q3 2013$995,000
+56.2%
251,948
-17.0%
0.00%0.0%
Q2 2013$637,000303,4200.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2016
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders